Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA

(AZN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about ASTRAZENECA
06/24LONDON STOCK EXCHANGE : FTSE 100 steady, Sino-U.S. trade talks back in focus
RE
06/19ASTRAZENECA : Breztri Aerosphere (PT010) approved in Japan for patients with chr..
PU
06/19ASTRAZENECA : Lynparza approved in Japan for 1st-line maintenance therapy in BRC..
PU
06/19ASTRAZENECA : Bevespi Aerosphere approved by the Japanese Ministry of Health, La..
PU
06/19ASTRAZENECA : Lynparza approved in Japan for 1st-line
AQ
06/19ASTRAZENECA : Bevespi Aerosphere approved by the Japanese
AQ
06/19ASTRAZENECA : Breztri Aerosphere (PT010) approved in Japan for
AQ
06/18LONDON STOCK EXCHANGE : FTSE 100 enjoys best day in four months after Draghi's '..
RE
06/18ASTRAZENECA : Lynparza gets EU nod as first-line ovarian cancer maintenance trea..
RE
06/18ASTRAZENECA : Lynparza approved in the EU for 1st-line maintenance treatment of ..
PU
06/18ASTRAZENECA : Lynparza approved in the EU for 1st-line
AQ
06/17ASTRAZENECA : GSK pharma head flags need for speed in high-pressure drug market
RE
06/17ASTRAZENECA : Study Shows Cancer Drug Calquence Increases Time Without Disease P..
DJ
06/17ASTRAZENECA : Calquence significantly prolonged the time patient
AQ
06/15ASTRAZENECA : CALQUENCE® (acalabrutinib) Significantly Prolonged the Time Patien..
BU
More most relevant news
All news about ASTRAZENECA
06/24LONDON STOCK EXCHANGE : FTSE 100 steady, Sino-U.S. trade talks back in focus
RE
06/19ASTRAZENECA : Breztri Aerosphere (PT010) approved in Japan for patients with chr..
PU
06/19ASTRAZENECA : Lynparza approved in Japan for 1st-line maintenance therapy in BRC..
PU
06/19ASTRAZENECA : Bevespi Aerosphere approved by the Japanese Ministry of Health, La..
PU
06/19ASTRAZENECA : Lynparza approved in Japan for 1st-line
AQ
06/19ASTRAZENECA : Bevespi Aerosphere approved by the Japanese
AQ
06/19ASTRAZENECA : Breztri Aerosphere (PT010) approved in Japan for
AQ
06/18LONDON STOCK EXCHANGE : FTSE 100 enjoys best day in four months after Draghi's '..
RE
06/18ASTRAZENECA : Lynparza gets EU nod as first-line ovarian cancer maintenance trea..
RE
06/18ASTRAZENECA : Lynparza approved in the EU for 1st-line maintenance treatment of ..
PU
More news
Sector news : Pharmaceuticals - NEC
05:57pAbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
05:10pNestlé, Novartis Among Companies at Risk of London Trading Ban -- 2nd Update
DJ
03:06pAbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
02:23pABBVIE : S&P Puts AbbVie on Watch Negative After Allergan Deal
DJ
01:53pNestlé, Novartis at Risk of London Trading Ban -- Update
DJ
More sector news : Pharmaceuticals - NEC
Upcoming event on ASTRAZENECA